跳至主要内容
临床试验/NCT03517904
NCT03517904已完成不适用

Comparison of Intravascular Ultrasound-Guided vs. Angiography-guided Angioplasty and Dual-antiplatelet v. Triple-antiplatelet Therapy for Outcomes of Drug-coated Balloon in the Treatment of Femoropopliteal Artery Disease (IVUS-DCB)

Yonsei University2 个研究点 分布在 1 个国家目标入组 237 人开始时间: 2016年5月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
237
试验地点
2
主要终点
Procedures lesion stenosis degree

研究概览

简要总结

  • Prospective, randomized, controlled, multi-center study
  • A total of 240 subjects with femoropopliteal artery disease will be included according to inclusion and exclusion criteria.
  • Patients will be randomized in a 1:1 manner into IVUS-guided or angiography-guided intervention group.
  • Second 1:1 randomization into dual antiplatelet therapy (aspirin + clopidogrel) or triple antiplatelet therapy (aspirin + clopidogrel + cilostazol) is optional
  • All patients will be treated with drug-coated balloons (In.PACT Admiral) for femoropopliteal lesions.
  • Bare metal self-expandable stents will be used in addition according to findings of IVUS or angiography such as severity of arterial dissection or residual stenosis.
  • Patients will be followed clinically for 1 year after the procedure.
  • Ankle-brachial index and Image study follow-up (Duplex US or CT angiography) will be performed at 1 year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 19 years or older
  • Symptomatic peripheral artery disease:
  • Moderate or severe claudication (Rutherford category 2 or 3)
  • Critical limb ischemia (Rutherford category 4 or 5)
  • Femoropopliteal artery disease (stenosis > 50%)
  • ABI <0.9
  • Patients with signed informed consent

排除标准

  • Acute critical limb ischemia
  • Severe critical limb ischemia (Rutherford category 6)
  • Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel, cilostazol, or contrast agents
  • Patients requiring oral anticoagulation using warfarin or NOAC
  • Age > 85 years
  • Severe hepatic dysfunction (> 3 times normal reference values)
  • Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis
  • LVEF < 40% or clinically overt congestive heart failure
  • Pregnant women or women with potential childbearing
  • Life expectancy <1 year due to comorbidity
  • Previous bypass surgery or stenting in the target femoropopliteal artery
  • Untreated inflow disease of the ipsilateral pelvic or femoropopliteal arteries (more than 50% stenosis or occlusion)

结局指标

主要结局

Procedures lesion stenosis degree

时间窗: at 12 months

Absence of restenosis \>50% by Duplex ultrasound, CT angiography, or catheter-based angiography

次要结局

  • Survival free from target vessel revascularization(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验